Compare ALLO & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | PKST |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.4M | 574.7M |
| IPO Year | 2018 | 2014 |
| Metric | ALLO | PKST |
|---|---|---|
| Price | $2.57 | $20.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | $8.40 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 4.5M | 455.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $105,981,000.00 |
| Revenue This Year | N/A | $12.08 |
| Revenue Next Year | $140,929.80 | $10.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $10.70 |
| 52 Week High | $2.80 | $20.97 |
| Indicator | ALLO | PKST |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 79.90 |
| Support Level | $2.14 | $20.72 |
| Resistance Level | $2.71 | $20.92 |
| Average True Range (ATR) | 0.24 | 0.03 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 75.00 | 85.00 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.